28. Claire S. Allardyce and Paul J. Dyson, 2001, ‘’Ruthenium in medicine; current clinical use and future perspective,’’j. platinum metals , rev.. 45(2):61-69
29. Yaw Kai Yan,{ Michael Melchart, Abraha Habtemariam and Peter J. Sadler,2005,’’ Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes’’.j.The Royal Society of Chemistry 2005: 4761-4776
30. Wee Han Ang [a]Paul J. Dyson*[a] .2009, ‘’Classical and non-classical ruthenium based anti-cancer drugs : Towards Targeted Chemotherapy’’ ,J. Inorg. Chem. 2006: 4003-4018
33. Laura MASlER03, Maurizio ONIST03, Enzo ALESSIO',G iovanni MESTRONi and Spiridione GARBlSA3,1996, Down-Regulation Of Tumour Gelatinase/Inhibitor Balance And Preservation Of Tumour Endothelium
35. Angela Casini, Andrei Karotki, Chiara Gabbiani, Francesco Rugi, Milan Vaák, Luigi Messori and Paul J. Dyson, Reactivity of an antimetastatic organometallic ruthenium compound with metallothionein-2: relevance to the mechanism of action ,j. Metallomics, 2009, 1, 434